SCHEMBL4273375

SCHEMBL4273375

OC[C@H]1OC[C@@H](O)C1O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16707273 1.00
SCHEMBL608371 1.00
SCHEMBL4420375 1.00
SCHEMBL91129 1.00
SCHEMBL23181030 1.00
SCHEMBL1425304 1.00
SCHEMBL23273618 1.00
SCHEMBL10098563 1.00
SCHEMBL12964371 1.00
SCHEMBL2621328 1.00

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170348414-A1 NOVEL SYNTHETIC ANTICANCER, ANTIFUNGAL, AND ANTIBACTERIAL VACCINES WAYNE STATE UNIVERSITY (US) 2017-12-07 US disclosed
WO-2017030684-A1 DEHYDRATIVE CYCLIZATION OF PENTITOLS USING WATER-TOLERANT LEWIS ACID CATALYSTS UNDER MILD CONDITIONS AND DERIVATIVES ARCHER DANIELS MIDLAND COMPANY (US) 2017-02-23 WO disclosed
EP-1947092-B1 Method for producing nucleic acid base having perfluoroalkyl group TOSOH CORP (JP) 2015-04-15 EP disclosed
US-8106184-B2 Nicotinoyl riboside compositions and methods of use CORNELL UNIVERSITY (US) 2012-01-31 US disclosed
US-7608597-B2 Methods and compositions for treating hepatitis C virus IDENIX PHARMACEUTICALS, INC. (US) 2009-10-27 US disclosed
US-20090247557-A1 PARTIAL AND FULL AGONISTS OF A1 ADENOSINE RECEPTORS GILEAD SCIENCES, INC. 2009-10-01 US disclosed
US-20070117765-A1 Nicotinoyl riboside compositions and methods of use CORNELL RESEARCH FOUNDATION INC. 2007-05-24 US disclosed